Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Żaneta Witas
Institution:
Medical University of Lodz
Observed institution:
Medical University of Lodz
ORCID:
0009-0000-0857-4816
Observed ORCID:
0009-0000-0857-4816
OpenAlex ID:
A5114509186
Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk
2024
·
Damian Mikulski
, Marcin Kamil Kędzior
, et al.
·
Cancers
·
6
PDF
Real-world utility of platelet count, hemoglobin, and iron levels as predictors of clinical response to vedolizumab in patients with ulcerative colitis: a retrospective, single-center study in Poland
2026
·
Aleksandra Sobolewska-Włodarczyk
, Jakub Orliński
, et al.
·
BMC Gastroenterology
Daratumumab–lenalidomide–dexamethasone (DRd) vs. lenalidomide–dexamethasone in patients with relapsed/refractory multiple myeloma — Polish early real-world experience following DRd reimbursement in the B.54 drug program
2025
·
Julia Piotrowska
, Katarzyna Płoszka
, et al.
·
Acta Haematologica Polonica
PDF
Show more works
View as search
Works count:
3
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type